Given the significant roles of STAT3 and PTEN, and the close interaction of miR-216a with both of them, miR-216a is an important molecule in cancer and further investigations are warranted to further demonstrated the clinical utility of miR-216a in ovarian cancer. This evidence concerns the gene STAT3 and cancer.